![Thomas Uhlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Uhlin
No open positions remaining
Health Technology
Profile
Thomas Uhlin was the Chief Executive Officer of Aprea Therapeutics AB and held Principal positions at Orexo AB and Doxa AB.
Former positions of Thomas Uhlin
| Companies | Position | End |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| DOXA AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Doxa AB
 Doxa AB Medical SpecialtiesHealth Technology Develops, manufactures, and commercializes bio ceramic dental products | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
- Stock Market
- Insiders
- Thomas Uhlin
